ASGN vs FRSH
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ASGN exhibits strong financial health with a Piotroski F-Score of 7/9, indicating solid operational and balance sheet fundamentals. The company trades near fair value based on the Graham Number of $52.86, with a current price of $51.04, while forward P/E of 10.26 suggests discounted earnings expectations. Despite healthy margins and a strong balance sheet (Current Ratio 1.99, Debt/Equity 0.68), revenue and earnings are contracting YoY (-1.90% and -17.90% respectively), offsetting valuation appeal. Analysts concur with a 'hold' rating and target price of $51.17, aligning closely with current levels.
Freshworks exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a very clean balance sheet (Debt/Equity 0.04). While the company is undervalued relative to its growth (PEG 0.50) and consistently beats earnings estimates, it is plagued by severe negative price momentum and bearish insider sentiment. The current price of $7.94 sits slightly above the Graham Number ($7.13), suggesting a fair valuation but lacking a catalyst for a reversal.
Compare Another Pair
Related Comparisons
ASGN vs FRSH: Head-to-Head Comparison
This page compares ASGN Incorporated (ASGN) and Freshworks Inc. (FRSH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.